ENAMINE
13.12.2023 09:01:36 CET | Business Wire | Press release
The two leading experts in the exploration of ultra-large make-on-demand chemical spaces join forces to spark a new era of drug discovery. Chief research chemicals provider Enamine and software innovator BioSolveIT have officially joined forces to establish the world's most comprehensive chemical space exploration platform. This strategic partnership is destined to reshape the landscape of chemical research, providing unprecedented benefits for drug hunters worldwide: more compounds to choose from, at the most competitive prices, with maximum speed of delivery and reliability. This new and exclusive alliance is based on and aims to supersede the already enormously successful REAL concept that has transformed and accelerated the hunt for new chemical entities in the fight against human diseases, in crop protection, and animal health, by providing access to billions of compounds on demand.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231211141956/en/
The alliance between BioSolveIT and Enamine will be game-changing in the pursuit of innovation within the pharma industry. Leveraging their respective strengths and expertise, the two companies are poised to create a synergy that will vastly expand today’s possibilities in discovering new chemical entities. The exclusive partnership will cover all aspects of chemical space exploration, from making larger and larger portions of chemical space accessible through trailblazing software solutions for ligand and structure-based exploration, and ultimately to synthesis at unprecedented success rates and delivery times.
Key advantages awaiting researchers worldwide:
- Exponential growth of novel IP: The combined expertise will unlock novel chemical matter at an unprecedented rate, providing trillions of new opportunities for drug discovery and development.
- Tailored chemical spaces: BioSolveIT’s unique algorithms coupled with Enamine’s vast chemistry expertise will enable clients to dive much deeper into chemical spaces, including bespoke spaces customized for clients’ needs.
- Massive savings along the DMTA cycle: Discovery of novel chemical entities within minutes on standard computers, compound sourcing up to 90% less expensive, and well over 80% successful syntheses, all within at most 3-4 weeks.
Professor Dr. Andrey Tolmachov, Founder and CEO at Enamine, says: "Over the past few years, BioSolveIT has taken virtual screening to a whole new level. I am very impressed by their algorithms that handle billions of virtual compounds as if they were only a few hundred thousand. Their chemical space exploration techniques and our make-on-demand offering are a perfect match.” Tolmachov continues: “Researchers can cherry-pick exactly those molecules that are interesting to them, and we successfully synthesize and ship these worldwide in record time.”
Dr. Christian Lemmen, CEO of BioSolveIT, appraises: "Enamine is really an outstanding supplier in this field. Whomever you ask, Enamine is their first choice when it comes to compound sourcing with the highest reliability at unprecedented speed. During these tough times, this is even more admirable.” Lemmen explains further: “Together, we have only just begun to redefine drug discovery via chemical space exploration. Our shared knowledge will help researchers and, ultimately, patients around the world.”
About BioSolveIT GmbH
BioSolveIT is a globally acting medicinal chemistry informatics and services company. It is renowned for its superior software solutions for affinity estimation, structure-based design, ligand-based design, high-throughput virtual screening, library design, and analysis. Their fast, visual, and easy computational technologies help innovate pharmaceutical research with a proven track record in almost all big pharma companies, amongst them AstraZeneca, F. A. Hoffmann-LaRoche, BASF, Bayer, Boehringer Ingelheim, Novartis, Pfizer, Sanofi, and many others. BioSolveIT’s infiniSee platform rapidly became an industry standard for navigation in molecular chemical spaces of unparalleled sizes. BioSolveIT software is loaded with award-winning algorithms. Profiting from radically simple user interfaces, the company’s applications address medicinal chemists and computational experts alike.
BioSolveIT is headquartered in Sankt Augustin, Germany. Support and sales offices are located in Boston, MA, and San Diego, CA, USA. Distribution partners maintain offices in Japan, China, South Korea, and India.
About Enamine Ltd.
Headquartered in Kyiv, Ukraine, Enamine is a scientifically driven integrated discovery Contract Research Organization with unique partnering opportunities in exploring new chemical space. The company combines access to the in-house produced screening compounds (4M in stock) and building blocks (300K in stock) with a comprehensive platform of integrated discovery services to advance and accelerate the efforts in Drug Discovery. Enamine has developed the largest offering of make-on-demand compounds that includes trillions of Enamine REAL molecules and over a billion of Enamine MADE building blocks. The company’s unique knowledge-based approach allows for fast and inexpensive delivery of novel entities from the above make-on-demand chemical space.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231211141956/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Canada to Join the NATO Innovation Fund to Advance the Local Defence, Security and Resilience Ecosystem21.11.2026 17:00:00 CET | Press release
Canada becomes the 25th Allied nation to back the NATO Innovation Fund, gaining access to €1.1 billion in mission-aligned capital and a co-investor network spanning the Alliance Canada announced today it is joining the NATO Innovation Fund, becoming the 25th Allied nation to commit to backing deep tech innovation to address the needs of NATO nations. The Government of Canada is committing EUR 64,590,000 (approximately CAD $100 million) to the firm, with the Business Development Bank of Canada (BDC) holding and managing Canada’s investment in the Fund. This brings total commitments to the NATO Innovation Fund to more than EUR 1.1 billion. Canadian membership will give domestic innovators access to patient capital, opportunities to accelerate the adoption of their technology by governments and businesses across the Alliance, a large network of co-investors, and lessons learned from the NIF’s work to date across 24 participating nations. “Canada has the talent, the innovation, and the amb
Persona Earns CEN/TS 18099 High Certification for Injection Attack Detection21.11.2026 15:30:00 CET | Press release
Independent evaluation of Persona's Android SDK confirms defenses against deepfakes and other injected media at the top level of the first standard Persona, the leading global identity platform, today announced that its Android SDK has earned CEN/TS 18099 High certification for injection attack detection (IAD). High certification is the top level of the European standard. The evaluation was run by CLR CERT, the certification body of Cabinet Louis Reynaud (CLR) Labs. CLR Labs is accredited under ISO/IEC 17025, the international standard for testing laboratories, and it edits CEN/TS 18099. This certificated injection attack detection is available to all Persona customers and can be activated by working with Persona's team. Injection attacks skip the camera entirely. Instead of holding a photo or mask up to a lens, fraudsters use virtual cameras, emulators and tampered devices to feed stolen, manipulated, or AI-generated media straight into the verification flow. To the system, the result
Verlinvest to Facilitate China Resources’ Full Exit From Oatly20.11.2026 22:30:00 CET | Press release
Proposed facilitation of China Resources’ exit from Oatly requires a tender offer because of Swedish law requirements Verlinvest recommends that Oatly shareholders and holders of ADSs do not tender their shares or ADSs. Verlinvest, the global, family-backed consumer-focused evergreen investment company, today announced it has entered into an agreement to acquire China Resources Enterprise, Limited’s (“China Resources”) indirect interests in Oatly Group AB (publ) (Nasdaq: OTLY) (“Oatly”), the world’s original and largest oat drink company. The transaction builds on Verlinvest’s investment in Oatly since 2016 and reinforces its conviction in the company’s long-term potential. A change in strategic direction of state-owned enterprise China Resources informed its decision to fully exit its investment in Oatly. China Resources worked constructively with Verlinvest to identify the best path for it to do so in recognition of the complexity of their joint holding structure. Under the agreement
Picsart Opens the AI Behind Its Platform to Developers & Businesses20.11.2026 20:54:00 CET | Press release
With Picsart Platform, developers can build their own video, audio, image features using 250+ models from 30+ providers, alongside Picsart's own editing models, through one API, CLI or MCP server. Key Takeaways One bundle, four ways to build: the API, the CLI, a playground to test models, and Picsart Media Studio, an MCP server that works with compatible AI assistants. One integration for image, video, audio and text generation from 250+ models across 30+ providers, with the freedom to switch models as a product evolves. Self-serve users pay per generation at competitive, published rates. Developers get access to Picsart's proprietary editing models, like Enhance and background removal, which are only available on Picsart Platform. Picsart, the AI media production and distribution platform backed by Sequoia Capital and SoftBank Vision Fund 2, today launched Picsart Platform - a multimodal creative AI hub that gives developers the technology behind the platform used by more than 100 mil
NetJets Becomes Official Private Aviation Provider of the Hahnenkamm Races in Kitzbühel20.11.2026 18:45:00 CET | Press release
The Partnership brings together two brands committed to excellence, precision and exceptional experiences NetJets, the global leader in private aviation, is delighted to announce its newest partnership with the Hahnenkamm Races in Kitzbühel, Austria, becoming the event's Official Private Aviation Provider. The Hahnenkamm Races are among the most prestigious and celebrated events in world alpine skiing. They attract athletes, business leaders, international guests and winter sports enthusiasts from around the world. Through this partnership, NetJets and the Hahnenkamm Races are aligning two brands renowned for excellence, precision and world-class experiences. The partnership is an exciting addition to NetJets' growing portfolio of premium lifestyle and sporting partnerships, offering Owners unique opportunities to access one of Europe's most iconic winter sporting events. Alongside premium hospitality and unforgettable behind-the-scenes experiences, the collaboration will help create e
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
